Dr. Angelidou is a Board-certified Neonatologist at Beth Israel Deaconess Medical Center (Boston, MA), Principal Investigator and Clinical Lead at the Precision Vaccines Program (PVP) in Boston Children’s Hospital, and Assistant Professor in Pediatrics at Harvard Medical School. She obtained her medical degree and doctoral degree in Immunopharmacology from the University of Athens in Greece, completed clinical training in Pediatrics at the University of Texas Southwestern and Children’s Medical Center at Dallas, TX, and Neonatal-Perinatal Medicine at the Harvard Combined Training Program in Neonatology, where she also served as Chief Fellow.
Funded by the NIH, her research program focuses on characterizing vaccine off-target effects in vivo and in vitro using systems biology approaches, incorporating them in clinical trial design, and harnessing them to optimize pediatric immunization schedules. With her clinical background and engagement in pre-clinical and human clinical vaccine studies, Dr. Angelidou’s long-term goal is to bridge translational investigation and clinical innovation to promote child health.